Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series.
Germano F, Bellucci M, Grisanti S, Beronio A, Grazzini M, Coco E, Tassinari T, Della Cava F, De Michelis C, Baldi O, Sivori G, Murialdo A, Cabona C, Durando P, Uccelli A, Schenone A, Franciotta D, Benedetti L. Germano F, et al. Among authors: tassinari t. J Neurol Sci. 2022 Sep 15;440:120330. doi: 10.1016/j.jns.2022.120330. Epub 2022 Jun 25. J Neurol Sci. 2022. PMID: 35802961 Free PMC article.
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group; Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Lees KR, et al. Lancet. 2010 May 15;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6. Lancet. 2010. PMID: 20472172
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.
Sormani MP, Inglese M, Schiavetti I, Carmisciano L, Laroni A, Lapucci C, Da Rin G, Serrati C, Gandoglia I, Tassinari T, Perego G, Brichetto G, Gazzola P, Mannironi A, Stromillo ML, Cordioli C, Landi D, Clerico M, Signoriello E, Frau J, Ferrò MT, Di Sapio A, Pasquali L, Ulivelli M, Marinelli F, Callari G, Iodice R, Liberatore G, Caleri F, Repice AM, Cordera S, Battaglia MA, Salvetti M, Franciotta D, Uccelli A; CovaXiMS study group on behalf of the Italian Covid-19 Alliance in MS. Sormani MP, et al. Among authors: tassinari t. EBioMedicine. 2021 Oct;72:103581. doi: 10.1016/j.ebiom.2021.103581. Epub 2021 Sep 22. EBioMedicine. 2021. PMID: 34563483 Free PMC article.
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
Sormani MP, Schiavetti I, Inglese M, Carmisciano L, Laroni A, Lapucci C, Visconti V, Serrati C, Gandoglia I, Tassinari T, Perego G, Brichetto G, Gazzola P, Mannironi A, Stromillo ML, Cordioli C, Landi D, Clerico M, Signoriello E, Cocco E, Frau J, Ferrò MT, Di Sapio A, Pasquali L, Ulivelli M, Marinelli F, Pizzorno M, Callari G, Iodice R, Liberatore G, Caleri F, Repice AM, Cordera S, Battaglia MA, Salvetti M, Franciotta D, Uccelli A; CovaXiMS study group. Sormani MP, et al. Among authors: tassinari t. EBioMedicine. 2022 Jun;80:104042. doi: 10.1016/j.ebiom.2022.104042. Epub 2022 May 5. EBioMedicine. 2022. PMID: 35526306 Free PMC article.
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study.
Cancelloni V, Buratti M, Tsivgoulis G, Furie KL, Tadi P, Caso V, Becattini C, Agnelli G, Zedde M, Abdul-Rahim AH, Alberti A, Venti M, de Magistris IL, Acciarresi M, D'Amore C, Mosconi MG, Cimini LA, Cappellari M, Putaala J, Tomppo L, Tatlisumak T, Bandini F, Marcheselli S, Pezzini A, Sohn SI, Lorenzini G, Tassi R, Guideri F, Acampa M, Ntaios G, Karagkiozi E, Athanasakis G, Makaritsis K, Sagris D, Adamou A, Vadikolias K, Palaiodimou L, Chondrogianni M, Mumoli N, Galati F, Sacco S, Tiseo C, Corea F, Ageno W, Bellesini M, Silvestrelli G, Ciccone A, Mancuso M, Orlandi G, Pascarella R, Tassinari T, Rueckert C, Baldi A, Toni D, Lettieri F, Giuntini M, Lotti EM, Flomin Y, Pieroni A, Kargiotis O, Karapanayiotides T, Halvatsiotis P, Monaco S, Baronello MM, Csiba L, Szabò L, Chiti A, Giorli E, Del Sette M, Imberti D, Zabzuni D, Doronin B, Volodina V, Michel P, Vanacker P, Barlinn K, Pallesen LP, Kepplinger J, Deleu D, Gourbali V, Yaghi S, Paciaroni M; RAF, R. A. F.-NOACs Investigators. Cancelloni V, et al. Among authors: tassinari t. Neurol Sci. 2024 May 22. doi: 10.1007/s10072-024-07555-z. Online ahead of print. Neurol Sci. 2024. PMID: 38775860
Risk factors for a first epileptic seizure after stroke: a case control study.
Leone MA, Tonini MC, Bogliun G, Gionco M, Tassinari T, Bottacchi E, Beghi E; ARES (Alcohol Related Seizures) Study Group. Leone MA, et al. Among authors: tassinari t. J Neurol Sci. 2009 Feb 15;277(1-2):138-42. doi: 10.1016/j.jns.2008.11.004. Epub 2008 Dec 6. J Neurol Sci. 2009. PMID: 19059614
91 results